Transplant (Hematologic) Cancer Studies Currently Recruiting Participants at the University of Chicago Comprehensive Cancer Center

Study Number Title
10-064-B Molecular characterization of hematopoietic malignancies
11-0118 KIR Genotyping for Unrelated Donor (URD) Selection Prior to Hematopoietic Cell Transplantation (HCT) for AML: Selecting a Favorable KIR Donor
IRB12-1191 Pilot study of Prophylactic Dose-Escalation Donor Lymphocyte Infusion After T Cell Depleted Allogeneic Stem Cell Transplant in High Risk Patients With Hematologic Malignancies
IRB12-1924 A Prospective Study of Optimal Cord Selection for Haplo-Cord Transplantation: Targeting the Inherited Paternal Antigen (IPA) and Matching for the Non-Inherited Maternal Antigen (NIMA)
IRB12-1926 A Randomized Study of Combined Haplo-Identical Transplantation vs. Double Umbilical Cord Blood Transplantation in Patients with Hematologic Malignancies
IRB12-2161 A Phase II Study Evaluating the Safety and Efficacy of Subcutaneous Plerixafor for the Mobilization and Transplantation of HLA-Matched Sibling Donor Hematopoietic Stem Cells in Recipients with Hematological Malignancies
12-1856 The University of Chicago Transplant Immunology and Immunogenetics Laboratory Research Registry and Specimen Collection Protocol for Biomedical Research
IRB14-0569 A Pilot Study Examining the Use of an Interdisciplinary Educational Checklist for Allogeneic Stem Cell Transplant Patients
IRB14-0711 A Phase I, Multicenter, Open-Label, Dose-Escalation Combination Study Of Pomalidomide, Marizomib, And Low-Dose Dexamethasone (PMD) In Subjects With Relapsed Or Refractory Multiple Myeloma.
12993B Collection and Use of Mobilized Peripheral Blood Stem Cells from Patients with Hematologic Malignancies
15147A Collection of Research Blood and/or Marrow Samples in Donors Undergoing Bone Marrow, Stem Cell or Lymphocyte Collection.
15953A Protocol for a research database for hematopoietic Stem Cell Transplanation and Marrow Toxic Injuries _ REPLACES 13239B
15961A Protocol for a Research Sample Repository For Allogeneic Hematopioetic Stem Cell Transplanation_ REPLACES 12590A

To learn more about cancer clinical trials or to make an appointment, call toll-free 1-855-702-8222 (adult trials) or 1-773-702-6808 (pediatric trials). Although our objective is to provide an updated listing of clinical trials, please note that a listing here does not guarantee that a trial is open or available to any specific patient. Additional trials may be available that are not listed. Complete information is available only from a treating physician.